Raleigh, NC · Founded 2021 · Privately Held (backing)
Developer of advanced therapeutics designed to address unmet needs in the management of late-stage chronic kidney diseases. Pathalys Pharma is based in Raleigh, NC and was founded in 2021. Its last known valuation is $295 million. It has raised $266 million.
Last price · $/share
—
Implied valuation
$295.0M
Total raised
$266.0M
Last round
—
Cap table — not yet on record
Pathalys Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pathalys Pharma with a free account
·The complete investor list: 12 names
·Watch Pathalys Pharma: the Monday email on marks, rounds and moves
